Research Focus

Former Employee. Radiology; Clinical Research Manager

Recent additions – View all

1. Correlation of molecular markers including mutations with clinical outcomes in advanced non small cell lung cancer (NSCLC) patients (pts) treated with gefitinib, chemotherapy or chemotherapy and gefitinib in IDEAL and INTACT clinical trials

   Meeting Abstract

   Lynch, T. J.; Bell, D.; Haber, D.; Johnson, D.; Giaccone, G.; Fukuoka, M.; Kris, M.; Herbst, R.; Krebs, A.; Ochs, J.
   Journal of Clinical Oncology (2005)

   Fulltext@MSK | Save
2. Cigarette smoking history predicts sensitivity to erlotinib: Results of a phase II trial in patients with bronchioloalveolar carcinoma (BAC)

   Meeting Abstract

   Kris, M. G.; Sandler, A.; Miller, V.; Cespon, M.; Zakowski, M.; Pizzo, B.; Venkatraman, E.; Gomez, J.; Johnson, D.; Carbone, D.
   Journal of Clinical Oncology (2004)

   Fulltext@MSK | Save
3. Sequential immunization of melanoma patients with GD3 ganglioside vaccine and anti-idiotypic monoclonal antibody that mimics GD3 ganglioside

   Journal Article

   Chapman, P. B.; Wu, D.; Ragupathi, G.; Lu, S.; Williams, L.; Hwu, W. J.; Johnson, D.; Livingston, P. O.
   Clinical Cancer Research (2004)

   Fulltext@MSK | Save